Fidelity National to buy Chicago Title

Article Abstract:

Fidelity National Financial Inc. has reached an agreement to purchase Chicago Title Corp. for $1.2 billion (1.1 billion euros). The deal involves shares and cash. The deal also creates the largest title-insurance firm in the US. Fidelity National agreed to pay $52 per share to Chicago Title, its larger competitor. The deal represents the largest in the consolidation of the title insurance industry.

Comment:

Fidelity National Financial to purchase Chicago Title for $1.2 billion (1.1 billion euros)

Asset sales & divestitures, Acquisitions & mergers, Insurance, Insurance Carriers and Related Activities, Direct Property and Casualty Insurance Carriers, Title Insurance, Mergers, acquisitions and divestments, Insurance industry, Fidelity National Financial Inc., Chicago Title Corp.

---

Crackdown puts corporations, executives in new legal peril

Article Abstract:

United States Securities and Exchange Commission have cracked down on American corporations and fraud post-Enron. The Commission has regulated deferred-prosecution agreements, the company is charged with criminal behavior but puts reform measures in place and on a certain date the potential charges are dropped.

Legal issues & crime, Government regulation (cont), Government expenditures, Government regulation, Police Protection, Legal/Government Regulation, Fraud, Economic aspects, Company legal issue, Laws, regulations and rules, Investigations, Corporate governance, Economic policy, United States. Securities and Exchange Commission

---

Northrop's net income rises 13%, as U.S. defense spending climbs

Article Abstract:

Northrop Grumman Corp. posted an increase of 13% in its net income for the 2003 second quarter. The company was helped by the increase in U.S. defense spending.

Sales, profits & dividends, Finance, Company sales and earnings, Defense industry, Company earnings/profit, Northrop Grumman Corp., Defence industry

Similar abstracts:

• Abstracts: A possible delay in Arcelor deal? U.S. Steel agrees to buy Canada's Stelco: deal worth $1.1 billion reflects new emphasis on higher-value lines
• Abstracts: Pfizer's shares sag on earnings outlook. Merck's Board adopts separation-benefits plan
• Abstracts: Untying the knot. China trips up its barefoot lawyers. Lost jobs: playing the election game
• Abstracts: Just say 'No' to Big Pharma. Thailand takes on drug patents. Asia's AIDS battlefield
• Abstracts: Oil-price drop challenges OPEC unity: cartel to weigh output cut, sharing the pain as internal rifts threaten long-term viability

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.